KLAR — Klaria Pharma Holding AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK123.23m
- SEK124.47m
- SEK8.99m
Brief: Klaria Pharma Q1 Loss At SEK 20.3 Million
Brief: Klaria Pharmaceuticals Enters Into Agreement With Fluimed
Brief: Patent For Klaria's Sumatriptan Alginate Film Granted In Russia
Brief: Klaria Pharma Q4 Loss After Tax Widens To SEK 39.1 Mln
Brief: Patent For Klaria's Sumatriptan Alginate Film To Be Granted In Mexico
Brief: Klaria Pharma Acquires Royalty Rights From FFT Medical
Brief: Klaria Q3 2021 Loss At SEK 15.2 Mln
Brief: Klaria Pharma: Approval By U.S. Patent And Trademark Office Of New Patent Application
Brief: Klaria Pharma Q2 Loss Widens To SEK 15.9 Mln
Brief: Klaria Pharma Holding Signs Cooperation Agreement With Hemply Balance
Brief: Jamaica Promotions Corp Announces Major Pharmaceutical Partnership Between Pure Jamaican And Sweden's Klaria Pharma
Brief: Klaria Pharma Announces New SEK 50 Million Financing Agreement
Brief: Klaria Pharma Gets Patent In Usa For Sumatriptan Alginatfilm
Brief: Klaria Pharma Holding Q1 Other Income Rises To SEK 31.3 Mln
Brief: Klaria Pharma Reports Successful Outcome Of Pivotal Bioequivalence Study With Sumatriptan Alginate Film
Brief: Klaria Pharma Holding Unit Signs Cooperation Agreement With Pure Jamaican Limited
Brief: Klaria Pharma Holding AB (Publ) - Enters Option Agreement With Imbrium Therapeutics
Brief: Klaria Pharma Announces Patent Approval In Europe
Brief: Klaria Pharma Q4 Net Loss Widens To SEK 17.0 Million